The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s biologics contract development market report forecasts the biologics contract development market size to grow to $10.29 Billion by 2027, with a CAGR (compound annual growth rate) of more than 10%.

Learn More On The Biologics Contract Development Market Report 2023 – https://www.thebusinessresearchcompany.com/report/biologics-contract-development-global-market-report

Biologics Contract Development Market Size Forecast
The global biologics contract development market is expected to grow from $6.27 billion in 2022 to $7.00 billion in 2023 at a compound annual growth rate (CAGR) of 11.61%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The biologics contract development market size is expected to reach $10.29 billion in 2027 at a CAGR of 10.13%.

North America held the largest biologics contract development market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Biologics Contract Development Market Driver ­– Rise In The Prevalence Of Chronic Diseases
For instance, according to data published in April 2021 by the World Health Organization, a Switzerland-based health organization for international public health, 41 million people die every year due to chronic diseases globally, close to 71% of all deaths. Therefore, the rising prevalence of chronic diseases will drive the biologics contract development market.

Request for A Sample Of The Global Biologics Contract Development Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8219&type=smp

Key Biologics Contract Development Market Trend – Technological Advancement
Major companies in the biologics contract development market are integrating advanced technologies to sustain their position in the market. For instance, in January 2022, Lonza, a Switzerland-based contract manufacturing and development solutions company, launched bYlok technology platform to design and manufacture bispecific antibodies. It helps to solve the light-heavy chain mispairing issue with high yields, >95% accuracy, and the ability to maintain a mAb-like format. It can be accessed by pharma and biotech companies through a simple research license.

Biologics Contract Development Market Segment
1) By Source: Microbial, Mammalian, Others Soruces
2) By Indication: Oncology, Immunological disorders, Cardiovascular disorders, Hematological disorders, Others Indications
3) By Product Service: Cell Line Development, Process Development, Others Product Services

Biologics Contract Development Market Major Players and Strategies
Major players in the biologics contract development market are WuXi Biologics, Abzena Ltd., Fujifilm Diosynth Biotechnologies, KBI Biopharma, AGC Biologics, Thermo Fisher Scientific Inc., LakePharma Inc., GenScript, Bionova Scientific Inc., Boehringer Ingelheim BioXcellence, STC Biologics, Siegfried Evionnaz SA, BioAgilytix Labs Inc., Samsung BioLogics, and Forge Biologics.

In February 2022, Recipharm, a Sweden-based pharmaceutical contract development and manufacturing organization, acquired Vibalogics and Arranta Bio for an undisclosed amount. This acquisition will strengthen Recipharm’s presence in advanced therapy medicinal products and enable it to expand virotherapy manufacturing capabilities in the US. Vibalogics is a Germany-based contract development and manufacturing organization. Arranta Bio is a US-based contract development and manufacturing organization.

The Biologics Contract Development Global Market Report 2023 covers regional data on biologics contract development market size, biologics contract development market trends and drivers, opportunities, strategies, and biologics contract development market competitor analysis. The countries covered in the biologics contract development market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Biologics contract development refers to companies that provide biologics development and manufacturing services to pharmaceutical corporations on a contract basis. The biologics contract development is used to outsource the manufacturing of biologics on contracts to focus on the marketing, R&D, and branding of products.

View More Reports Related To The Biologics Contract Development Market –
Biologics Global Market Report 2023
Contract Development Manufacturing Organizations Global Market Report 2023
Contract Research And Manufacturing Services (CRAMS) Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: